These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21079216)

  • 21. ACP Journal Club. Prior intensive insulin treatment reduced long-term risk for peripheral neuropathy in type 1 diabetes.
    Di Napoli M
    Ann Intern Med; 2010 Oct; 153(8):JC4-3. PubMed ID: 20956699
    [No Abstract]   [Full Text] [Related]  

  • 22. ACP Journal Club. Intensive insulin therapy did not reduce mortality more than conventional therapy in septic shock treated with corticosteroids.
    Deans KJ; Minneci PC
    Ann Intern Med; 2010 May; 152(10):JC5-5. PubMed ID: 20479022
    [No Abstract]   [Full Text] [Related]  

  • 23. ADVANCE: action in diabetes and vascular disease.
    Patel A; Chalmers J; Poulter N
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACP Journal Club. A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years.
    Mahon J
    Ann Intern Med; 2013 Jan; 158(2):JC4. PubMed ID: 23318338
    [No Abstract]   [Full Text] [Related]  

  • 25. ACP Journal Club. Intensive glucose control increased risk for death and severe hypoglycemia in critically ill adults.
    Kovalaske MA; Gandhi GY
    Ann Intern Med; 2009 Aug; 151(4):JC2-5. PubMed ID: 19687479
    [No Abstract]   [Full Text] [Related]  

  • 26. ACP journal club. Meta-analysis: more intensive statin therapy prevents major vascular events.
    Smith DA
    Ann Intern Med; 2011 May; 154(10):JC5-03. PubMed ID: 21576521
    [No Abstract]   [Full Text] [Related]  

  • 27. ACP Journal Club. Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes.
    Tsapas A
    Ann Intern Med; 2009 Feb; 150(4):JC2-12. PubMed ID: 19238610
    [No Abstract]   [Full Text] [Related]  

  • 28. ACP Journal Club: metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CAD.
    Tanner M
    Ann Intern Med; 2013 Apr; 158(8):JC4. PubMed ID: 23588769
    [No Abstract]   [Full Text] [Related]  

  • 29. ACP Journal Club. Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes.
    Muthusamy K; Smith SA; Dinneen SF; Dennedy MC
    Ann Intern Med; 2009 Oct; 151(8):JC4-6, JC4-7. PubMed ID: 19841444
    [No Abstract]   [Full Text] [Related]  

  • 30. ACP Journal Club. Intensive primary care treatment reduced cardiovascular risk factors at 1 year in screen-detected type 2 diabetes.
    Elley CR; Kenealy T
    Ann Intern Med; 2009 May; 150(10):JC5-9. PubMed ID: 19451565
    [No Abstract]   [Full Text] [Related]  

  • 31. ACP Journal Club. Review: Intensive insulin therapy does not reduce mortality but increases severe hypoglycemia in hospitalized patients.
    Pastores SM
    Ann Intern Med; 2011 Jul; 155(2):JC1-12. PubMed ID: 21768578
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.
    Zhang CY; Sun AJ; Zhang SN; Wu CN; Fu MQ; Xia G; Wang KQ; Zou YZ; Ge JB
    Ann Med; 2010 May; 42(4):305-15. PubMed ID: 20429797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACP Journal Club. Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes.
    Merugu S
    Ann Intern Med; 2010 Oct; 153(8):JC4-2. PubMed ID: 20956698
    [No Abstract]   [Full Text] [Related]  

  • 34. ACP Journal Club. Implementation of an evidence-based feeding guideline did not reduce mortality in intensive care units.
    Ferri M; Adhikari N
    Ann Intern Med; 2009 May; 150(10):JC5-13. PubMed ID: 19451569
    [No Abstract]   [Full Text] [Related]  

  • 35. ACP Journal Club. Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy.
    Barrett-Connor E
    Ann Intern Med; 2011 Oct; 155(8):JC4-7. PubMed ID: 22007066
    [No Abstract]   [Full Text] [Related]  

  • 36. ACP Journal Club. Review: Aspirin does not reduce CV events but may reduce nonfatal stroke in peripheral artery disease.
    Mukherjee D
    Ann Intern Med; 2009 Sep; 151(6):JC3-5, JC3-4. PubMed ID: 19755351
    [No Abstract]   [Full Text] [Related]  

  • 37. ACP Journal Club: Review: Low BP targets do not reduce mortality or CV events in hypertension.
    McAlister FA
    Ann Intern Med; 2009 Nov; 151(10):JC5-6-7. PubMed ID: 19920264
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACP Journal Club. Daily multivitamin supplements did not reduce risk for major CV events over > 10 years in men.
    Fairfield KM
    Ann Intern Med; 2013 Feb; 158(4):JC8. PubMed ID: 23420255
    [No Abstract]   [Full Text] [Related]  

  • 40. ACP Journal Club. B-vitamin supplements did not reduce vascular events in patients with recent stroke or TIA.
    Barer D
    Ann Intern Med; 2011 Feb; 154(4):JC2-8. PubMed ID: 21320935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.